You just read:

Janssen to Present Data from Six Compounds Including Daratumumab and Ibrutinib at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

Janssen Research & Development, LLC

18 May, 2016, 17:01 ET